Kava's TCM appeal? Fiji Kava's new CEO on how the brand aims to tap into China market

By Tingmin Koe

03-Aug-2021 - Last updated on 03-Aug-2021 at 01:36 GMT

ASX-listed Fiji Kava is exploring how kava could be incorporated into traditional Chinese medicine (TCM) as it seeks to expand its market presence in China, its recently appointed CEO told us.

Read the full story here.

NIA top 10 stories

LISTEN: Gut microbiome, elderly, and HIV - Prof Balamurugan Ramadass on studying ‘overlooked’ populations at new India research centre

Healthy ageing: Nestle China launches company's first set of 'blue-hat' certified health foods for seniors

India's new RDA rules see increase in vitamin A, C, zinc levels, while biotin remains unchanged

2'-FL markets expanding: Taiwan the latest to approve use of HMO in infant and young children products

PepsiCo and probiotics: Imunele yogurt reduces frequency of upper respiratory tract infections among female subjects

Regulatory review: Postbiotics redefinition, Taiwan animal test ban, and Thailand's new fish oil standards

'Biggest priority': Bayer seeks to capture pan-India vitamin market with newly formed local team and star SKUs

Synbiotic formula restores gut microbiota in C-section delivered infants – Danone-funded trial

Malaysian supplements policy: Trade body MADSA calls for sales tax removal and less stringent rules for new formulations

Kava's TCM appeal? Fiji Kava's new CEO on how the brand aims to tap into China market

Related news

Show more

Follow us

Products

View more

Webinars

Upcoming editorial webinars

14 May 2024 Tue Webinar Healthy Ageing APAC

On-demand webinars

Nutra Champions Podcast

Nutra Champions Podcast

Headlines